by transparencyrx | May 12, 2025 | Uncategorized
With today’s Executive Order, President Trump is right to focus attention on U.S. drug prices but in reality, prescription costs won’t meaningfully change unless we confront the real powerbrokers: offshore global middlemen and PBMs owned by insurance giants. The...
by transparencyrx | May 7, 2025 | Uncategorized
Transparency-Rx, a trusted, not-for-profit coalition dedicated to changing drug pricing for the better, is excited to announce its newest member, EmpiRx Health. They join a growing list of transparent pharmacy benefit management companies, leading industry experts,...
by transparencyrx | Sep 20, 2024 | Uncategorized
Transparency-Rx applauds the Federal Trade Commission today for bringing federal anti-trust action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations...
